TB Research

Improved Outcomes With High-dose Isoniazid in Multidrug-resistant Tuberculosis Treatment in Haiti

Kathleen F. Walsh, Stalz Charles Vilbrun, Ariadne Souroutzidis, Sobieskye Delva, Guy Joissaint, L Mathurin, Oksana Ocheretina, Pierre Y. Crémieux, et al. (10 authors)

Clinical Infectious Diseases · 2019-01

Abstract

We report outcomes for a cohort of patients with multidrug-resistant tuberculosis who received high-dose isoniazid in Haiti. Patients who received high-dose isoniazid had a faster time to culture conversion and higher odds of successful outcome, despite high-level isoniazid resistance. This suggests high-dose isoniazid may have effectiveness even with phenotypic resistance.

MeSH terms

  • Isoniazid
  • Medicine
  • Tuberculosis
  • Culture conversion
  • Cohort
  • Multiple drug resistance
  • Internal medicine
  • Drug resistance